Abstract

The University of Wisconsin Clinical Cancer Center is a multidisciplinary, interdepartmental organization that facilitates high quality clinical and laboratory research training and cancer care. The Center Faculty, utilizing Center space and facilities, excels in laboratory and clinical research exploring cancer problems. Through its investigation of human cancer, it serves residents of Wisconsin and adjoining areas of Iowa and Illinois by providing optimal cancer care and innovative clinical trials. The Center offers unique opportunities to train cancer specialists in laboratory, clinical and statistical disciplines. Its outreach programs involve other cancer care and research institutions in the state as well as the public and professionals in the area. The Cancer Center Sup;port Grant to the UW Clinical Cancer Center aids in progressing towards the long term goal, reduction of the incidence, mortality and morbidity of human cancer. The broad objectives of the center are: 1. To undertake innovative laboratory and clinical research probing biologic problems in cancer. 2. To facilitate clinical applications of findings from research. 3. To improve cancer care through clinical trials. 4. To train specialists in cancer related fields. 5. To educate students, professionals and the public in Wisconsin about cancer.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014520-17
Application #
3101430
Study Section
Cancer Center Support Grant Review Committee (CCS)
Project Start
1976-01-01
Project End
1993-03-31
Budget Start
1989-04-01
Budget End
1990-03-31
Support Year
17
Fiscal Year
1989
Total Cost
Indirect Cost

  Institution

Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715

  Publications

Goel, Shreya; Ferreira, Carolina A; Chen, Feng et al. (2018) Activatable Hybrid Nanotheranostics for Tetramodal Imaging and Synergistic Photothermal/Photodynamic Therapy. Adv Mater 30:
Wei, Weijun; Ehlerding, Emily B; Lan, Xiaoli et al. (2018) PET and SPECT imaging of melanoma: the state of the art. Eur J Nucl Med Mol Imaging 45:132-150
Yu, Bo; Wei, Hao; He, Qianjun et al. (2018) Efficient Uptake of 177 Lu-Porphyrin-PEG Nanocomplexes by Tumor Mitochondria for Multimodal-Imaging-Guided Combination Therapy. Angew Chem Int Ed Engl 57:218-222
Ehlerding, Emily B; Lacognata, Saige; Jiang, Dawei et al. (2018) Targeting angiogenesis for radioimmunotherapy with a 177Lu-labeled antibody. Eur J Nucl Med Mol Imaging 45:123-131
Shea, Michael P; O'Leary, Kathleen A; Wegner, Kyle A et al. (2018) High collagen density augments mTOR-dependent cancer stem cells in ER?+ mammary carcinomas, and increases mTOR-independent lung metastases. Cancer Lett 433:1-9
Ko, Huaising C; Kimple, Randall J (2018) The Resident Individual Development Plan as a Guide for Radiation Oncology Mentorship. Int J Radiat Oncol Biol Phys 101:786-788
McDermott, Andrew J; Tumey, Tyler A; Huang, Mingwei et al. (2018) Inhaled Cryptococcus neoformans elicits allergic airway inflammation independent of Nuclear Factor Kappa B signalling in lung epithelial cells. Immunology 153:513-522
You, Xiaona; Kong, Guangyao; Ranheim, Erik A et al. (2018) Unique dependence on Sos1 in Kras G12D -induced leukemogenesis. Blood 132:2575-2579
Ferreira, Carolina A; Hernandez, Reinier; Yang, Yunan et al. (2018) ImmunoPET of CD146 in a Murine Hindlimb Ischemia Model. Mol Pharm 15:3434-3441
Conklin, Matthew W; Gangnon, Ronald E; Sprague, Brian L et al. (2018) Collagen Alignment as a Predictor of Recurrence after Ductal Carcinoma In Situ. Cancer Epidemiol Biomarkers Prev 27:138-145

Showing the most recent 10 out of 1528 publications